Novogene(SH:688315)2021-10-25 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥474,266,282.44, representing a year-over-year increase of 28.48%[7] - The net profit attributable to shareholders for Q3 2021 was ¥47,478,898.42, reflecting a significant increase of 105.75% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2021 was ¥39,912,560.35, up 94.18% year-over-year[7] - Total operating revenue for the first three quarters of 2021 reached ¥1,275,995,770.26, a 33.7% increase from ¥954,285,378.45 in the same period of 2020[34] - Net profit for the third quarter of 2021 was ¥131,029,348.76, a significant recovery from a net loss of ¥55,564,509.15 in the same quarter of 2020[34] - The total comprehensive income for the third quarter of 2021 was ¥125,556,224.37, compared to a loss of ¥56,533,496.23 in the same quarter of 2020[34] - Basic and diluted earnings per share for the first three quarters of 2021 were CNY 0.34, compared to a loss of CNY 0.15 in the same period of 2020[40] Research and Development - Research and development (R&D) expenses totaled ¥45,116,002.74 for Q3 2021, an increase of 65.25% compared to the same period last year[11] - R&D expenses accounted for 9.51% of operating revenue in Q3 2021, an increase of 2.11 percentage points year-over-year[11] - Research and development expenses for the third quarter of 2021 were ¥95,349,213.00, up from ¥78,702,531.64 in the same quarter of 2020, indicating a 21.1% increase[34] - The company is focused on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[30] Assets and Liabilities - Total assets at the end of Q3 2021 were ¥2,523,474,560.67, a 24.63% increase from the end of the previous year[11] - The company's total assets reached ¥2,523,474,560.67, up from ¥2,024,732,082.96 in the previous year[34] - Accounts receivable increased significantly to RMB 433,697,035.44 from RMB 321,999,155.20, reflecting a growth of approximately 34.7% year-over-year[26] - The company's inventory also saw an increase, rising to RMB 260,309,304.39 from RMB 201,581,129.33, which is a growth of around 29.1%[26] - Total current liabilities decreased to RMB 779,352,409.10 from RMB 897,478,042.40, showing a reduction of approximately 13.2%[29] - The company's total liabilities amounted to ¥815,302,474.89, down from ¥903,855,566.28 in the previous year[34] - The company's long-term equity investments remained stable at RMB 23,333,615.04, unchanged from the previous year[29] - The company’s total liabilities decreased, indicating improved financial health and stability[29] Cash Flow - The company reported a net cash flow from operating activities of -¥42,937,286.65 for the year-to-date period[11] - Cash inflow from operating activities totaled CNY 1,176,218,057.77, an increase from CNY 1,089,193,214.42 year-over-year[40] - Net cash outflow from operating activities was CNY -42,937,286.65, slightly worse than CNY -41,235,843.06 in the previous year[40] - Cash inflow from investment activities was CNY 827,809,806.35, up from CNY 473,712,687.54 in the same period last year[42] - Net cash outflow from investment activities was CNY -291,235,754.49, compared to a net inflow of CNY 40,292,203.88 in the previous year[42] - Cash inflow from financing activities was CNY 488,781,961.60, compared to CNY 276,118,796.66 in the same period last year[42] - Net cash inflow from financing activities was CNY 404,601,483.16, significantly higher than CNY 9,208,013.77 in the previous year[42] - The ending cash and cash equivalents balance was CNY 510,342,781.55, up from CNY 315,972,017.86 at the end of the previous year[42] Equity - Shareholders' equity attributable to the parent company reached ¥1,702,185,386.64, up 52.49% compared to the previous year[11] - The equity attributable to shareholders of the parent company increased to ¥1,702,185,386.64 from ¥1,116,250,391.49, marking a 52.4% growth[34] - Total equity remained stable at 1,120,876,516.68, unchanged from the previous period[51]